Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04927013 · ClinicalTrials.gov registry record · NA
Connecting Families to Overcome Ovarian Cancer
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 2,331
- Enrollment target
NCT04927013: Completed NA study, sponsored by Emory University.
NCT04927013 is a NA study that has completed, run by Emory University. The registered enrollment target is 2,331 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04927013, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,331 participants
- Enrollment target
Study Summary
This study tests a multi-component, low cost, message-based communication outreach intervention to engage ovarian cancer survivors and their at-risk relatives in considering cancer genetic services. The intervention includes foot-in-the-door techniques, tailored/targeted print, website support, and short messages to expand reach of prevention messages.
Primary Outcome
Survivor reach is assessed as the number of the eligible survivors identified and contacted by GCR who used their unique login to access the study website.
Interventions
- BEHAVIORAL Message-based Outreach Intervention for Survivors
- BEHAVIORAL Standard Outreach for Survivors
- BEHAVIORAL Message-based Outreach Intervention for Close Relatives
- BEHAVIORAL Standard Outreach for Close Relatives
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,331 participants |
| Start Date | 2021-07-24 |
| Est. Completion | 2023-02-21 |
| Phase | NA |
What the finished NCT04927013 record still lists
NCT04927013 is an interventional study that assigns participants to a tested intervention. Its 2,331 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% higher).
The record links to 0 conditions, and to 4 interventions - of which Message-based Outreach Intervention for Survivors is the first listed.
NCT04927013 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04927013 about?
NCT04927013 is a clinical study titled "Connecting Families to Overcome Ovarian Cancer". This study tests a multi-component, low cost, message-based communication outreach intervention to engage ovarian cancer survivors and their at-risk relatives in considering cancer genetic services. The intervention includes foot-in-the-door techniques, tailored/targeted print, website support, and ...
What is the current status of trial NCT04927013?
This trial is currently completed. It is a NA study. The enrollment target is 2,331 participants. The study started on 2021-07-24. Estimated completion is 2023-02-21.
What interventions are being tested in trial NCT04927013?
The interventions under investigation include: Message-based Outreach Intervention for Survivors (BEHAVIORAL), Standard Outreach for Survivors (BEHAVIORAL), Message-based Outreach Intervention for Close Relatives (BEHAVIORAL), Standard Outreach for Close Relatives (BEHAVIORAL).
Who is sponsoring clinical trial NCT04927013?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04927013's enrollment target sits among peer trials
2,331 46th of 2000 higher than 1,955 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
- NCT06824194 · 2,320 participants · Phase 3
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
- NCT03099850 · 2,345 participants
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI